About
Technology
Issues
FAQ
Search
Profile
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Main Topics
Most Cited Articles
Scientometrics
Avg Impact Factor
★★
Articles
★★★
Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Schools
›
Department of Stem Cell Transplantation and Cell
›
Top Articles
Department of Stem Cell Transplantation and Cellular Therapy
1.1K
(top 0.1%)
papers
26.0K
(top 1%)
citations
74
(top 1%)
h
-index
133
(top 1%)
g
-index
1.2K
all documents
28.6K
doc citations
2.7K
citing journals
1.1K
times ranked
Top Articles
#
Title
Journal
Year
Citations
1
Chimeric antigen receptor T-cell therapy — assessment and management of toxicities
Nature Reviews Clinical Oncology
2018
1,659
2
B cells and tertiary lymphoid structures promote immunotherapy response
Nature
2020
1,421
3
Mesenchymal Stem Cell Transition to Tumor-Associated Fibroblasts Contributes to Fibrovascular Network Expansion and Tumor Progression
PLoS ONE
2009
686
4
An inhibitor of oxidative phosphorylation exploits cancer vulnerability
Nature Medicine
2018
622
5
Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activity
Leukemia
2018
525
6
Phase 1 Results of ZUMA-1: A Multicenter Study of KTE-C19 Anti-CD19 CAR T Cell Therapy in Refractory Aggressive Lymphoma
Molecular Therapy
2017
498
7
A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCR
Blood
2012
437
8
International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials
Cytotherapy
2016
400
9
Indications for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation
Biology of Blood and Marrow Transplantation
2015
342
10
Engineering Natural Killer Cells for Cancer Immunotherapy
Molecular Therapy
2017
337
11
Tuning Sensitivity of CAR to EGFR Density Limits Recognition of Normal Tissue While Maintaining Potent Antitumor Activity
Cancer Research
2015
327
12
Double hit lymphoma: the
MD A
nderson
C
ancer
C
enter clinical experience
British Journal of Haematology
2014
310
13
Lenalidomide in combination with rituximab for patients with relapsed or refractory mantle-cell lymphoma: a phase 1/2 clinical trial
Lancet Oncology, The
2012
274
14
The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy
Blood
2016
245
15
Toward eliminating HLA class I expression to generate universal cells from allogeneic donors
Blood
2013
243
16
Indication and management of allogeneic stem cell transplantation in primary myelofibrosis: a consensus process by an EBMT/ELN international working group
Leukemia
2015
242
17
Natural killer cells in antitumour adoptive cell immunotherapy
Nature Reviews Cancer
2022
208
18
Similar Transplantation Outcomes for Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients with Haploidentical versus 10/10 Human Leukocyte Antigen–Matched Unrelated and Related Donors
Biology of Blood and Marrow Transplantation
2014
207
19
Oral lenalidomide with rituximab in relapsed or refractory diffuse large cell, follicular and transformed lymphoma: a phase II clinical trial
Leukemia
2013
197
20
Detection of MRD may predict the outcome of patients with Philadelphia chromosome–positive ALL treated with tyrosine kinase inhibitors plus chemotherapy
Blood
2013
190
21
Ibrutinib in combination with rituximab in relapsed or refractory mantle cell lymphoma: a single-centre, open-label, phase 2 trial
Lancet Oncology, The
2016
189
22
Management guidelines for paediatric patients receiving chimeric antigen receptor T cell therapy
Nature Reviews Clinical Oncology
2019
178
23
Mechanisms of nuclear content loading to exosomes
Science Advances
2019
176
24
Complement-Binding Donor-Specific Anti-HLA Antibodies and Risk of Primary Graft Failure in Hematopoietic Stem Cell Transplantation
Biology of Blood and Marrow Transplantation
2015
161
25
Once Daily i.v. Busulfan and Fludarabine (i.v. Bu-Flu) Compares Favorably with i.v. Busulfan and Cyclophosphamide (i.v. BuCy2) as Pretransplant Conditioning Therapy in AML/MDS
Biology of Blood and Marrow Transplantation
2008
159
26
The Warburg Effect in Leukemia-Stroma Cocultures Is Mediated by Mitochondrial Uncoupling Associated with Uncoupling Protein 2 Activation
Cancer Research
2008
153
27
Oncolytic Adenovirus and Tumor-Targeting Immune Modulatory Therapy Improve Autologous Cancer Vaccination
Cancer Research
2017
152
28
Manufacture of Clinical-Grade CD19-Specific T Cells Stably Expressing Chimeric Antigen Receptor Using Sleeping Beauty System and Artificial Antigen Presenting Cells
PLoS ONE
2013
143
29
US intergroup study of chemotherapy plus dasatinib and allogeneic stem cell transplant in Philadelphia chromosome positive ALL
Blood Advances
2016
142
30
Indications for Hematopoietic Cell Transplantation and Immune Effector Cell Therapy: Guidelines from the American Society for Transplantation and Cellular Therapy
Biology of Blood and Marrow Transplantation
2020
139
31
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune effector cell-related adverse events
Biology of Blood and Marrow Transplantation
2020
138
32
Personalizing Busulfan-Based Conditioning: Considerations from the American Society for Blood and Marrow Transplantation Practice Guidelines Committee
Biology of Blood and Marrow Transplantation
2016
130
33
PD-1 blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation
Blood
2019
129
34
Outlook for New CAR-Based Therapies with a Focus on CAR NK Cells: What Lies Beyond CAR-Engineered T Cells in the Race against Cancer
Cancer Discovery
2021
128
35
Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Myelofibrosis with Prior Exposure to Janus Kinase 1/2 Inhibitors
Biology of Blood and Marrow Transplantation
2016
127
36
Impact of aerosolized ribavirin on mortality in 280 allogeneic haematopoietic stem cell transplant recipients with respiratory syncytial virus infections
Journal of Antimicrobial Chemotherapy
2013
125
37
A phase 3 randomized study of 5-azacitidine maintenance vs observation after transplant in high-risk AML and MDS patients
Blood Advances
2020
122
38
A new approach to gene therapy using
Sleeping Beauty
to genetically modify clinical‐grade T cells to target
CD
19
Immunological Reviews
2014
121
39
Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: impact of tyrosine kinase inhibitor and minimal residual disease
Leukemia
2014
121
40
The role of the gastrointestinal microbiome in infectious complications during induction chemotherapy for acute myeloid leukemia
Cancer
2016
121
41
Advances in understanding the leukaemia microenvironment
British Journal of Haematology
2014
120
42
Exosomes harbor B cell targets in pancreatic adenocarcinoma and exert decoy function against complement-mediated cytotoxicity
Nature Communications
2019
120
43
Regulation of HIF-1α signaling and chemoresistance in acute lymphocytic leukemia under hypoxic conditions of the bone marrow microenvironment
Cancer Biology and Therapy
2012
119
44
Risk factors associated with late cytomegalovirus reactivation after allogeneic stem cell transplantation for hematological malignancies
Bone Marrow Transplantation
2007
117
45
Targeting the αv integrin/TGF-β axis improves natural killer cell function against glioblastoma stem cells
Journal of Clinical Investigation
2021
117
46
Batf is important for IL-4 expression in T follicular helper cells
Nature Communications
2015
114
47
ILF2 Is a Regulator of RNA Splicing and DNA Damage Response in 1q21-Amplified Multiple Myeloma
Cancer Cell
2017
114
48
Toxicity management after chimeric antigen receptor T cell therapy: one size does not fit 'ALL'
Nature Reviews Clinical Oncology
2018
114
49
Haploidentical Natural Killer Cells Infused before Allogeneic Stem Cell Transplantation for Myeloid Malignancies: A Phase I Trial
Biology of Blood and Marrow Transplantation
2016
113
50
Predictors of Radiation Pneumonitis in Patients Receiving Intensity Modulated Radiation Therapy for Hodgkin and Non-Hodgkin Lymphoma
International Journal of Radiation Oncology Biology Physics
2015
110
site/software ©
exaly
; All materials licenced under
CC by-SA
.